Table of contents

Therapeutics

• Modafinil improves symptoms of ADHD compared with placebo in young people (25 July, 2006)
• Early intervention has no effect on symptoms in people with first episode, non-affective psychosis, although it may improve overall function and medication adherence (25 July, 2006)
• Review: higher rates of attrition in antipsychotic treatment arms of placebo controlled trials than in trials with active comparators (25 July, 2006)
• Olanzapine and risperidone may improve neurocognition more than haloperidol in people with schizophrenia who continue treatment for 52 weeks (25 July, 2006)
• Olanzapine is associated with more rapid weight gain than haloperidol in people with first episode psychosis (25 July, 2006)
• Maintenance treatment with olanzapine reduces relapse in people with bipolar I disorder who have responded to acute olanzapine treatment (25 July, 2006)
• Topiramate improves psychopathological symptoms and quality of life in women with borderline personality disorder (25 July, 2006)
• Mirtazapine reduces social anxiety and improves quality of life in women with social phobia (25 July, 2006)
• IMPACT collaborative care improves depression in elderly patients in primary care in the longer term (25 July, 2006) Free
• Vardenafil improves comorbid erectile dysfunction and mild depression (25 July, 2006)
• Review: an early sustained response can occur in the first and second weeks of antidepressant treatment for major depressive disorder (25 July, 2006)
• Review: case management in primary health care improves symptoms and drug adherence in people with major depression (25 July, 2006)
• Review: cognitive behavioural therapy is an effective treatment for depression, panic disorder, and generalised anxiety disorder, but may be less effective in severe cases (25 July, 2006)
• Case management and vouchers improve uptake of methadone treatment programmes (25 July, 2006)